BIO 2018

In the last few years consumer genomics has grown in both its offerings and legitimacy.

The road to digital innovation in the pharma and healthcare space is going to take players across industries — from tech developers and engineers to researchers and clinicians, according to a panel of digital-focused VPs speaking at BIO 2018 in Boston.

Pharma companies are increasingly embracing the use of wearables and other connected devices to streamline and improve data collection in clinical trials.

Digital technologies are cementing their place across healthcare, and the pharmaceutical sector is no exception.

A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston.

It’s no secret investors have been pouring billions of dollars into digital health companies, and it seems the life sciences sector has taken notice.